Specifically, amplification mutations of TUBA1B were linked to elevated TUBA1B expression in the cancer tissues of patients with BRCA, KIRC, KIRP, and LUAD and may serve as a risk factor affecting the prognosis of patients with these types of cancer. Here, TUBA1B is linked to cancer.